News

Gary Lowenthal Joins Focused Ultrasound Foundation’s Council

The Focused Ultrasound Foundation is pleased to welcome Gary Lowenthal to its Council, a dedicated group of goodwill ambassadors who work closely with the Board of Directors and staff to provide advice and assist with raising funds and building awareness.

Mr. Lowenthal is a retired educator, entrepreneur, and executive with a career spanning education, international service, and business leadership.

He began his professional journey as a teacher serving in the Peace Corps, teaching in underserved communities in Fiji. Upon returning to the US, he held an executive position at Bloomingdale’s before founding The Boyds Collection Ltd. in 1979, a company that became a leader in the plush and figurine market renowned for its lovingly crafted handmade collectibles. As “the Head Bean Hisself,” he personally designed much of the original Boyds Bears lineup, infusing each piece with his sense of humor, warmth, and a clear eye for character.

In addition to his business ventures, Mr. Lowenthal remained dedicated to education and taught entrepreneurship to budding innovators at Mount St. Mary’s University.

“Gary’s unique blend of creativity, entrepreneurial spirit, and dedication to service makes him a tremendous asset to the Foundation’s Council,” said Foundation Chairman Neal F. Kassell, MD. “His insight and energy will strengthen our efforts to advance this transformative technology and expand its access to patients.”

“It’s an honor to join the Foundation’s Council and support such groundbreaking work,” Mr. Lowenthal said. “I’m inspired by the potential of focused ultrasound to revolutionize medicine, and I look forward to contributing to a mission that has real, lasting impact on people’s lives.”

Born and raised in New York City, Mr. Lowenthal earned a bachelor of science degree in biology and a master’s degree in biology and education from Alfred University.

Read more here.

Recent News

07/17/2025

RIVANNA’s next-generation ultrasound guidance platform and AI-driven imaging software receive FDA 510(K) clearance

RIVANNA®, developers of world-first imaging-based medical technologies, announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) regarding the Accuro® 3S diagnostic ultrasound system and SpineNav-AI™ image processing software. This clearance authorizes the use of both technologies in United States hospital and clinical settings, providing anatomical guidance during needle or

07/15/2025

CEL-SCI Announces Closing of $5.7 Million Offering Priced At-The-Market Under NYSE American Rules

CEL-SCI Corporation (“CEL-SCI” or the “Company”) (NYSE American: CVM), a clinical stage cancer immunotherapy company, announced the closing of its best-efforts offering of 1,500,000 shares of its common stock. Each share of common stock was sold at an offering price of $3.82 per share, priced at-the-market under NYSE American rules. Total gross proceeds from the

07/15/2025

Civica Appoints Dave Sehgal as Chief Manufacturing Officer and Supply Chain Officer

Civica announced the appointment of Dave Sehgal, Ph.D. as its new Chief Manufacturing Officer and Supply Chain Officer, effective July 21. In this role, Dr. Sehgal will lead Civica’s manufacturing strategy and operations, reporting directly to Ned McCoy, President and CEO. “We are excited to welcome Dave to our leadership team,” said McCoy. “His deep